Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRC-CHAMP: ASA for CRC Prevention
NCT05402124Phase 2Unknown
- Sponsor
- University of Calgary
- Start
- Jul 2022
- Primary completion
- Mar 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in colorectal cancer (CRC), sponsored by University of Calgary. Status: unknown.
02
Drugs
aspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05402124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05402124.